10-Q: NewLake Capital Navigates Cannabis Market Headwinds

NewLake Capital Partners reports mixed Q3 2025 results with slight revenue growth, but faces tenant defaults and increased interest expenses amid a volatile cannabis market.

Summary

• Net income attributable to common stockholders for Q3 2025 was $6.666 million, up from $6.422 million in Q3 2024.
• Total revenue for Q3 2025 was $12.587 million, a slight increase from $12.554 million in Q3 2024.
• For the nine months ended September 30, 2025, net income attributable to common stockholders was $20.282 million, compared to $20.087 million for the same period in 2024.
• Total revenue for the nine months ended September 30, 2025, increased to $38.728 million from $37.618 million in 2024.
• Funds From Operations (FFO) attributable to common stockholders (diluted) for Q3 2025 was $10.651 million, up from $10.260 million in Q3 2024.
• Adjusted Funds From Operations (AFFO) attributable to common stockholders (diluted) for Q3 2025 was $11.022 million, an increase from $10.763 million in Q3 2024.
• Two tenants, AYR Wellness and Revolutionary Clinics, vacated properties during Q3 2025 and ceased rent payments, leading to property carrying costs of $145 thousand for the quarter.
• The Revolving Credit Facility's interest rate increased to 8.25% as of September 30, 2025, from a fixed rate of 5.65% through May 5, 2025.
• The company declared a Q3 2025 cash dividend of $0.43 per share, maintaining an annualized dividend of $1.72 per share.
• As of September 30, 2025, the company owned 34 properties across 12 states with 11 tenants, comprising 19 dispensaries and 15 cultivation facilities.

Sentiment

Score: 4

Explanation: While revenue and net income saw slight increases, the significant tenant defaults and increased interest expenses, coupled with ongoing regulatory uncertainty in the cannabis market, present notable challenges. The positive financial metrics are somewhat overshadowed by these operational and market headwinds.

Positives

• Net income attributable to common stockholders increased to $6.666 million in Q3 2025 from $6.422 million in Q3 2024, and to $20.282 million for the nine months ended September 30, 2025, from $20.087 million in 2024.
• Total revenue saw a slight increase in Q3 2025 to $12.587 million and a more significant increase for the nine months ended September 30, 2025, to $38.728 million.
• FFO and AFFO both increased for the three and nine months ended September 30, 2025, demonstrating improved operational cash flow metrics.
• Annual rent escalations across the portfolio generated approximately $241 thousand of additional rental income in Q3 2025 and $0.8 million for the nine months ended September 30, 2025.
• The company maintains a conservatively leveraged portfolio with only $7.6 million outstanding on its Revolving Credit Facility and $82.4 million in available funds.
• General and administrative expenses decreased by $0.460 million in Q3 2025 compared to Q3 2024, primarily due to reduced compensation and professional fees.
• The company's stock repurchase program was extended through December 31, 2026, with approximately $8.2 million remaining availability.

Negatives

• Two significant tenants, AYR Wellness and Revolutionary Clinics, ceased rent payments and vacated properties during Q3 2025, impacting rental income and leading to vacant properties.
• The Revolving Credit Facility's interest rate transitioned from a fixed 5.65% to a variable rate of 8.25% as of September 30, 2025, increasing interest expense by $55 thousand in Q3 2025 and $0.2 million for the nine months ended September 30, 2025.
• Property carrying costs of $145 thousand were incurred in Q3 2025 for the newly vacant properties.
• The cannabis rescheduling process remains stalled with no new hearing dates set, creating ongoing regulatory uncertainty for the industry.
• Inflation, while easing, remained elevated at approximately 3.0% for the twelve-month period ended September 30, 2025, potentially impacting operating costs.

Risks

• Cannabis remains illegal under federal law, posing a risk of strict enforcement that could hinder the company's and its tenants' business plans.
• Reduced liquidity of common stock due to limited availability of clearing firms for securities settlement.
• General economic conditions, including changes in financial condition of tenants due to fiscal, monetary, and regulatory policies, could adversely affect operations.
• Adverse economic or real estate developments, nationally or in specific markets, could impact property values and rental income.
• Increases in interest rates and operating costs, as well as the impact of inflation, could negatively affect financial performance.
• The competitive environment in the cannabis real estate market may diminish acquisition opportunities or pressure rental rates.
• Lack of tenant security deposits could impact the ability to recover rents in case of tenant default.
• Concentration of tenants in certain geographical areas increases exposure to regional economic or regulatory changes.
• Failure to generate sufficient cash flows to service outstanding indebtedness.
• Rates of defaults on, early terminations of, or non-renewal of leases by tenants, including significant tenants, could materially affect business.
• Some tenants have limited operating histories and may be more susceptible to payment and other lease defaults.
• The company's ability to acquire properties in its identified pipeline successfully, on anticipated timelines or costs, is not guaranteed.
• Lack or insufficient amounts of insurance could lead to significant losses.
• Bankruptcy or insolvency of a significant tenant or a substantial number of smaller tenants poses a material risk.
• Access to certain financial resources, including banks and other financial institutions, may be limited for the cannabis industry.
• Changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates, could adversely affect the company.

Future Outlook

The company expects cash flow from continuing operations, combined with cash reserves, to be sufficient to fund business operations, pay dividends, and cover debt service over the next twelve months. Acquisitions and unfunded improvement allowance costs may require funding from borrowings, equity issuance, or LPI Units. The company remains vigilant in monitoring evolving market dynamics, emphasizing prudent financial oversight and proactive tenant engagement. The potential rescheduling of cannabis to Schedule III is viewed as a pivotal milestone that could lift IRS Section 280E restrictions and pave the way for expanded medical research, though the regulatory timeline remains uncertain.

Management Comments

• We remain vigilant in monitoring these evolving market dynamics. Prudent financial oversight and proactive tenant engagement remain central to our strategy as we navigate an operating environment shaped by elevated interest rates, cautious investor sentiment, and sector-specific risks.
• We believe broader financial challenges within the cannabis industry including debt strain and refinancing difficulties highlight the importance of disciplined tenant underwriting and portfolio management.
• We believe this renewed push alongside speculation about potential executive action has added momentum and uncertainty to the regulatory landscape.
• If cannabis rescheduling were to occur, it would represent a pivotal milestone for the industry. We believe rescheduling would lift current restrictions under IRS Section 280E, which currently prevents cannabis operators from claiming certain tax deductions, resulting in excessively high effective tax rates for state-legal cannabis businesses.

Industry Context

The cannabis industry continues to face significant macroeconomic uncertainty, including persistent inflation, elevated interest rates, and constrained credit markets. Many operators are experiencing margin compression and debt strain, with billions in loans maturing by 2026 and limited refinancing options. The stalled federal rescheduling process for marijuana adds to regulatory limbo, though legislative efforts and executive branch signals suggest potential movement. These challenges underscore the importance of disciplined tenant underwriting and portfolio management for REITs like NewLake Capital Partners operating in this specialized sector.

Comparison to Industry Standards

• The filing highlights that many operators across the cannabis industry continue to face margin compression and debt strain, with billions in loans maturing by 2026 and limited access to refinancing options. This suggests that NewLake Capital Partners' experience with tenant defaults (AYR Wellness, Revolutionary Clinics) is reflective of broader industry challenges rather than isolated incidents.
• The company's focus on long-term, single-tenant, triple-net sale-leaseback and build-to-suit transactions is a common strategy for REITs in specialized sectors, aiming for stable, predictable income streams, though the cannabis industry's unique federal illegality adds a layer of risk not present in other REIT sectors.
• The company's low general and administrative expense ratio of 1.2% of total assets suggests efficient internal management, which could be a competitive advantage compared to other cannabis real estate providers, especially those with external management structures.

Management Changes

Corporate Governance

Legal Proceedings

• Not currently a party to any material legal proceedings.
• May from time to time be a party to various claims and routine litigation arising in the ordinary course of business, but does not believe the final outcome of any current matters is reasonably likely to have a material adverse effect.

Related Party Transactions

• HG Vora Capital Management, LLC, West Investment Holdings, LLC, West CRT Heavy, LLC, Gary and Mary West Charitable Trust, Gary and Mary West 2012 Gift Trust and WFI Co-Investments (collectively, the West Stockholders) and NL Ventures LLC (Pangea) hold certain nomination rights with respect to members of the board of directors, pursuant to an Investor Rights Agreement.

Stakeholder Impact

• Shareholders: Impacted by dividend payments ($0.43 per share declared for Q3 2025), potential share price volatility due to tenant issues and regulatory uncertainty, and potential dilution from ATM program or value enhancement from share repurchases.
• Employees/Officers: Affected by stock-based compensation plans (RSUs, PSUs) and changes in compensation expense due to resignations.
• Tenants: Directly impacted by the company's enforcement of lease rights, particularly AYR Wellness and Revolutionary Clinics, and by the broader industry's financial and regulatory challenges.
• Creditors (Revolving Credit Facility lenders): Affected by the increase in interest rates on the facility and the company's compliance with financial covenants.
• Customers (indirectly, as tenants' customers): Potential impact on product availability or pricing if tenant operational challenges persist or worsen.

Next Steps

• Actively market the vacant Fitchburg, MA, Pottsville, PA, and Sparks, NV properties for lease.
• Enforce all rights available under applicable lease agreements for non-performing tenants.
• Pursue a sale of the Hartford property under the amended lease agreement with C3 Industries.
• Invest in new properties with C3 Industries pursuant to its right of first refusal agreement to offset reallocated rent from the Hartford property sale.
• Monitor evolving market dynamics, including interest rates, inflation, and trade policies, and adapt financial strategies accordingly.
• Continue to monitor the federal cannabis rescheduling process and legislative efforts for potential regulatory changes.

Key Dates

Recommendation

The company exhibits a mixed financial performance with slight revenue and net income growth, and healthy FFO/AFFO. However, significant tenant defaults (AYR Wellness, Revolutionary Clinics) and increased interest expenses due to variable rate debt introduce considerable operational headwinds and uncertainty. The stalled federal cannabis rescheduling process further complicates the regulatory landscape. While the company maintains a strong balance sheet with low leverage and ample liquidity, these challenges warrant a cautious approach. A 'hold' recommendation is appropriate as investors should monitor the resolution of tenant issues, the impact of rising interest rates, and progress on cannabis rescheduling before making further investment decisions.

Keywords

Cannabis REIT, Real Estate Investment Trust, Cannabis Industry, Sale-Leaseback, Triple-Net Lease, SEC Filing, 10-Q, Financial Results, Tenant Default, Marijuana Rescheduling, Real Estate Acquisitions, Dividend, Revolving Credit Facility, OTCQX, NLCP